You are here: Home > Institute of Excellence (CPD) > CPD Events > Evidence-Based Myopia Management

Evidence-Based Myopia Management

Date: 11/06/205 - 02/07/2025 (AEST)

Venue: Online, NSW, 2052

Provider: School of Optometry and Vision Science, University of New South Wales

Contact: Pauline Kang, [E] p.kang@unsw.edu.au, [P] 0290656112

11 Jun 25, 11:00 am - 12:00 pm

18 Jun 25, 12:00 pm - 1:00 pm

25 Jun 25, 12:00 pm - 1:00 pm

2 Jul 25, 12:00 pm - 1:00 pm

Activity Outline

The course offers an in-depth understanding and knowledge of the latest evidence-based optical, pharmacological, and behavioural interventions to appropriately manage progressive myopia. You will be equipped with practical skills to be able to identify individuals at risk of myopia development and progression and develop personalised management plans for simple and complex myopia cases.

Through the progression of this course, you will also learn how to critically appraise the literature regarding new therapies, so that you can develop life-long skills to be able to independently evaluate the literature on new therapies as they are introduced.

Learning Objectives

  • Identify key risk factors for myopia development or progression.
  • Describe the benefits and limitations of current optical, pharmacological and behavioural interventions for progressive myopia.
  • Apply specialised ophthalmic technologies and methodologies necessary for appropriate management of progressive myopia.
  • Demonstrate knowledge to be able to competently design, develop and revise a management plan for progressive myopia involving optical, pharmacological or behavioural interventions.
  • Communicate in an ethical and knowledgeable manner with patients and their parents and/or guardians of the management of their progressive myopia.

Max CPD hours awarded: 20.5 (6.5Ti 2T)

Session Information

Name
Welcome and Q&As Self-Assessment Survey
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
1
Duration of CPD Session/Module inclusive of Assessment Component
1
Name
Module 1 Asynchronous ▪Myopia classifications ▪Refractive error development ▪ Animal models of myopia Epidemiology of myopia ▪Monitoring myopia progression
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
5
Duration of CPD Session/Module inclusive of Assessment Component
5
Name
Module 2 Asynchronous ▪Fixed risk factors for myopia ▪ Modifiable risk factors for myopia ▪Outdoor time ▪ Near work behaviour
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
3
Duration of CPD Session/Module inclusive of Assessment Component
3
Name
Synchronous Modeule 1-2review webinar ▪ Case study analysis exercise
Clinical?
Yes
Interactive?
No
Therapeutic?
Yes
Duration of CPD Session/Module
2
Duration of CPD Session/Module inclusive of Assessment Component
2
Name
Module 3 Asynchronous ▪Spectacles for myopia control ▪ Contact lenses for myopia control ▪Orthokeratology for myopia control
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
3
Duration of CPD Session/Module inclusive of Assessment Component
3
Name
Module 3 Synchronous ▪Case study analysis exercise
Clinical?
Yes
Interactive?
Yes
Therapeutic?
Yes
Duration of CPD Session/Module
2
Duration of CPD Session/Module inclusive of Assessment Component
2
Name
Asynchronous Module 4 ▪Atropine for myopia control▪ Other pharmacological interventions for myopia control ▪ Clinical considerations
Clinical?
Yes
Interactive?
Yes
Therapeutic?
Yes
Duration of CPD Session/Module
2.5
Duration of CPD Session/Module inclusive of Assessment Component
2.5
Name
Module 4 Synchronous ▪Case study analysis exercise
Clinical?
Yes
Interactive?
Yes
Therapeutic?
Yes
Duration of CPD Session/Module
2
Duration of CPD Session/Module inclusive of Assessment Component
2

Acknowledgement of Country

In the spirit of reconciliation Optometry Australia acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respects to their Elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.